Vineet Laboratories Limited Defers Consideration of Financial Results Following Board Meeting

Vineet Laboratories Limited Defers Consideration of Financial Results Following Board Meeting​

Vineet Laboratories Limited held its Board of Directors meeting on Saturday, May 30, 2026. During the meeting, the Board was informed of the resignation of the Company Secretary and the Compliance Officer.

The primary item of business related to the consideration, approval, and adoption of the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, could not proceed. The Board determined that the results had not been considered or recommended by the Audit Committee.

Consequently, the consideration of the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, has been deferred. The company indicated that the revised date for the Audit Committee Meeting and the Board Meeting for considering and approving these financial results will be communicated in due course.

Trading Window Status Remains Closed​

The deferral of the Board Meeting has immediate implications for the company's market trading cycle. Previously, the Trading Window for dealing in the equity shares of the company was closed starting from April 01, 2026, and was set to reopen 48 hours after the announcement of the financial results.

Due to the postponement, the Trading Window will remain closed. It is expected to reopen 48 hours after the declaration of the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, on a date to be intimated subsequently.

VINEETLAB Stock Price Movement​

Shares of Vineet Laboratories Limited on Friday slipped by 2.86% to settle at ₹33.97. The stock saw significant trading interest, recording a total volume of 31,392 shares for the session.